000 | 01995 a2200589 4500 | ||
---|---|---|---|
005 | 20250514160622.0 | ||
264 | 0 | _c20031215 | |
008 | 200312s 0 0 eng d | ||
022 | _a0269-9370 | ||
024 | 7 |
_a10.1097/00002030-200317003-00002 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDjomand, Gaston | |
245 | 0 | 0 |
_aVirologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Côte d'Ivoire. _h[electronic resource] |
260 |
_bAIDS (London, England) _cJul 2003 |
||
300 |
_aS5-15 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
650 | 0 | 4 | _aAntiretroviral Therapy, Highly Active |
650 | 0 | 4 | _aCD4 Lymphocyte Count |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aCote d'Ivoire |
650 | 0 | 4 | _aDeveloping Countries |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGovernment Programs |
650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
650 | 0 | 4 |
_aHIV-1 _xisolation & purification |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInternational Cooperation |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aPilot Projects |
650 | 0 | 4 | _aProgram Evaluation |
650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xtherapeutic use |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aViral Load |
700 | 1 | _aRoels, Thierry | |
700 | 1 | _aEllerbrock, Tedd | |
700 | 1 | _aHanson, Debra | |
700 | 1 | _aDiomande, Fabien | |
700 | 1 | _aMonga, Bondo | |
700 | 1 | _aMaurice, Chantal | |
700 | 1 | _aNkengasong, John | |
700 | 1 | _aKonan-Koko, Regina | |
700 | 1 | _aKadio, Auguste | |
700 | 1 | _aWiktor, Stefan | |
700 | 1 | _aLackritz, Eve | |
700 | 1 | _aSaba, Joseph | |
700 | 1 | _aChorba, Terence | |
773 | 0 |
_tAIDS (London, England) _gvol. 17 Suppl 3 _gp. S5-15 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00002030-200317003-00002 _zAvailable from publisher's website |
999 |
_c14308360 _d14308360 |